Venetoclax for AML: Shifting Care from Hospital to Clinic | Aaron Goldberg, MD, PhD | #EHA2025

Venetoclax for AML: Shifting Care from Hospital to Clinic | Aaron Goldberg, MD, PhD | #EHA2025
Less Time in the Hospital: Real-World Benefits of Venetoclax for AML Patients | Aaron Goldberg, MD | #EHA2025
Promising New Combo Treatment Shows High Remission Rates in AML Patients with NPM1 and KMT2A Mutations | Harry Erba, MD | #EHA2025
Hope for Relapsed AML: Ziftomenib Shows Promise in NPM1-Mutated Leukemia | Eunice Wang, MD | #EHA2025
Skip navigation Search Create Avatar image Implementation of Hospital-Level Care at Home for Acute Leukemia | Nikesh Shah, MD | #EHA 2025
New Advances in Treating Acute Lymphoblastic Leukemia | Mark Litzow, MD | #EHA 2025
Improved Survival in Young B-ALL Patients with Blinatumomab | Mark Litzow, MD | #EHA 2025
Does Race Have an Impact on CLL Care? What the Latest Data? | Adam Kittai, MD #EHA2025